Selective Treatment of Multiple Sclerosis
The New England Journal of Medicine - March 2, 2006
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
The New England Journal of Medicine - March 2, 2006
Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis
The New England Journal of Medicine - March 2, 2006
Archive
© 2006 - 2007 MSPATIENTSFORCHOICE.ORG, All Rights Reserved |
Disclaimer
|
Website by SPX Studios
